Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

AbbVie's Imbruvica gets approval in Europe to treat Waldenstrom's macroglobulinemia US-based biopharmaceutical firm AbbVie has received marketing authorization from the European Commission (EC) for Imbruvica (ibrutinib) to treat Waldenstrom's macroglobulinemia (WM), a rare, slow growing blood cancer. Production & Manufacturing > Process & Production > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses
Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
Production & Manufacturing > Fine & Speciality Chemicals > News
CordenPharma agrees to purchase Peptisyntha from Solvay
By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
Production & Manufacturing > Fine & Speciality Chemicals > News

Process & Production

Neos resubmits ADHD drug application for FDA review
By PBR Staff Writer
Neos Therapeutics has resubmitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for its amphetamine XR orally disintegrating tablet (XR-ODT) product candidate, NT‐0202, to treat attention deficit hyperactivity disorder (ADHD).
Production & Manufacturing > Process & Production > News
Juno IND application given FDA nod for leukemia drug candidate JCAR015
By PBR Staff Writer
The US Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application of biopharmaceutical firm Juno Therapeutics for its product candidate JCAR015 to treat adults with relapsed/refractory acute lymphoblastic leukemia (r/r ALL).
Production & Manufacturing > Process & Production > News

OTC

Protecting Access to Pain Relief Coalition launches to ensure Americans have access to trusted pain relief
By PBR Staff Writer
The Protecting Access to Pain Relief (PAPR) Coalition officially launched to help ensure that American consumers continue to have access to, and choice of, safe and effective pain relief that is best suited to manage their condition.
Production & Manufacturing > OTC > News
CHPA welcomes House introduction of DXM Abuse Prevention Act
By PBR Staff Writer
The Consumer Healthcare Products Association (CHPA) is pleased to lend its strong support for the DXM Abuse Prevention Act, introduced into the US House of Representatives by US Reps. Bill Johnson (R-OH) and Doris Matsui (D-CA).
Production & Manufacturing > OTC > News

Manufacturing

Hikma agrees to acquires Roxane Laboratories for $1.18bn
Hikma Pharmaceuticals, the fast growing multinational pharmaceutical group, announces that it has agreed to acquire Roxane Laboratories and Boehringer Ingelheim Roxane (together, Roxane), from Boehringer Ingelheim.
Production & Manufacturing > Manufacturing > News
Merck improves immuno-oncology portfolio with acquisition of cCAM Biotherapeutics
Merck, known as MSD outside the United States and Canada, and cCAM Biotherapeutics announced that the companies have signed a definitive agreement under which Merck will acquire cCAM Biotherapeutics, a privately held biopharmaceutical company focused on the discovery and development of novel cancer immunotherapies.
Production & Manufacturing > Manufacturing > News